| Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial JW Denham, A Steigler, DS Lamb, D Joseph, S Turner, J Matthews, ... The lancet oncology 12 (5), 451-459, 2011 | 509 | 2011 |
| Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial JW Denham, A Steigler, DS Lamb, D Joseph, H Mameghan, S Turner, ... The lancet oncology 6 (11), 841-850, 2005 | 436 | 2005 |
| Phyllodes tumor of the breast Y Belkacémi, G Bousquet, H Marsiglia, I Ray-Coquard, N Magné, ... International Journal of Radiation Oncology* Biology* Physics 70 (2), 492-500, 2008 | 319 | 2008 |
| Validation of a malnutrition screening tool for patients receiving radiotherapy ML Ferguson, J Bauer, B Gallagher, S Capra, DRH Christie, BR Mason Australasian radiology 43 (3), 325-327, 1999 | 224 | 1999 |
| Turning subjective into objective: the BCCT. core software for evaluation of cosmetic results in breast cancer conservative treatment MJ Cardoso, J Cardoso, N Amaral, I Azevedo, L Barreau, M Bernardo, ... The Breast 16 (5), 456-461, 2007 | 207 | 2007 |
| Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network A Omlin, M Amichetti, D Azria, BF Cole, P Fourneret, P Poortmans, ... The Lancet Oncology 7 (8), 652-656, 2006 | 164 | 2006 |
| Primary and secondary bone lymphomas C Messina, D Christie, E Zucca, M Gospodarowicz, AJM Ferreri Cancer treatment reviews 41 (3), 235-246, 2015 | 142 | 2015 |
| Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group A Wirth, K Yuen, M Barton, D Roos, K Gogna, G Pratt, C MacLeod, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 130 | 2005 |
| Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced … JW Denham, D Joseph, DS Lamb, NA Spry, G Duchesne, J Matthews, ... The Lancet Oncology 15 (10), 1076-1089, 2014 | 117 | 2014 |
| An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer CF Sharpley, DRH Christie Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2007 | 108 | 2007 |
| Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer DRH Christie, CF Sharpley, V Bitsika Psycho‐Oncology 24 (9), 1002-1011, 2015 | 106 | 2015 |
| Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced … JW Denham, D Joseph, DS Lamb, NA Spry, G Duchesne, J Matthews, ... The Lancet Oncology 20 (2), 267-281, 2019 | 104 | 2019 |
| Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled … JW Denham, A Steigler, C Wilcox, DS Lamb, D Joseph, C Atkinson, ... The Lancet Oncology 9 (11), 1058-1068, 2008 | 102 | 2008 |
| Randomized trial of systemic therapy after involved-field radiotherapy in patients with early-stage follicular lymphoma: TROG 99.03 M MacManus, R Fisher, D Roos, P O’Brien, A Macann, S Davis, R Tsang, ... J Clin Oncol 36 (29), 2918-2925, 2018 | 95 | 2018 |
| A comparison of methods of cosmetic assessment in breast conservation treatment DRH Christie, MY O'brien, JA Christie, T Kron, SA Ferguson, CS Hamilton, ... The Breast 5 (5), 358-367, 1996 | 95 | 1996 |
| Factors determining esthetic outcome after breast cancer conservative treatment MJ Cardoso, J Cardoso, AC Santos, C Vrieling, D Christie, G Liljegren, ... The breast journal 13 (2), 140-146, 2007 | 93 | 2007 |
| Does resilience ‘buffer’against depression in prostate cancer patients? A multi‐site replication study CF Sharpley, V Bitsika, AC Wootten, DRH Christie European journal of cancer care 23 (4), 545-552, 2014 | 92 | 2014 |
| Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study) M Bruno Ventre, AJM Ferreri, M Gospodarowicz, S Govi, C Messina, ... The oncologist 19 (3), 291-298, 2014 | 90 | 2014 |
| Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial A Capp, M Inostroza-Ponta, D Bill, P Moscato, C Lai, D Christie, D Lamb, ... Radiotherapy and oncology 90 (3), 400-407, 2009 | 85 | 2009 |
| Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review SA Luis, DRH Christie, A Kaminski, L Kenny, MH Peres Journal of Medical Imaging and Radiation Oncology 53 (6), 559-568, 2009 | 79 | 2009 |
